跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IMAAVY - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
IMAAVY
Authorized
STANDARD
IMAAVY
Janssen Inc
🇨🇦 Health Canada
Approval Date
Feb 5, 2026
Approval ID
dde3ba843def6724
Company
Janssen Inc
Type
Standard
Approval Details
Approval Id
dde3ba843def6724
Drug Approval Canada Name
IMAAVY
Product Name
IMAAVY
Status
Approved
Status Date
2025-12-05
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Schedule D , Prescription
Ahfs
90:08.04
Atc Original
L04 IMMUNOSUPPRESSANTS
Aig Number
0167913001
Company Name
Janssen Inc
Company Address
19 Green Belt Drive Toronto Ontario Canada M3C 1L9
Company Detail Path
/organization/janssen-inc
Company Information
Pharmaceutical Company Name
Janssen Inc
Country Name
Canada
Province Name
Ontario
City Name
north york,ontario,country_ca
Address
19 Green Belt Dr
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 5, 2026
Approval ID
dde3ba843def6724
Type
Standard
Back to Health Canada Approvals